RECRUITING

Azithromycin Before Induction

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Official Title

Azithromycin to Prevent Chorioamnionitis in Women Undergoing Induction of Labor, a Randomized Control Trial

Quick Facts

Study Start:2023-08-07
Study Completion:2025-08-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06543290

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * • Third trimester of pregnancy defined as 28 0/7 weeks or more
  2. * Singleton pregnancy
  3. * Age 18-45
  4. * Induction of labor initiated for medical or obstetrical reason or electively over 39 weeks of gestation
  5. * No contraindication to vaginal delivery
  6. * Reassuring fetal heart rate tracing
  7. * Able and willing to provide informed consent
  1. * • Does not read or write in English or Spanish
  2. * Unable or unwilling to give informed consent
  3. * Use of antibiotic or antiviral agent within the last 7 days
  4. * Evidence of active infection at the time of initiation of induction (patients with rectovaginal group B streptococcus positive results will be allowed to participate as it is a colonizing organism, unless they show evidence of active infection)
  5. * Incarcerated Women
  6. * Active substance abuse
  7. * Age \< 18

Contacts and Locations

Study Contact

Kristina Nalbandyan, DO
CONTACT
8187306222
knalbandian@westernu.edu
Kristina Roloff, DO
CONTACT
9514427424
kristyroloff@gmail.com

Study Locations (Sites)

Arrowhead Regional Medical Center
Colton, California, 92324
United States

Collaborators and Investigators

Sponsor: Arrowhead Regional Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-07
Study Completion Date2025-08-07

Study Record Updates

Study Start Date2023-08-07
Study Completion Date2025-08-07

Terms related to this study

Additional Relevant MeSH Terms

  • Infections